In fact, Yoshinobu Saito et al.[8] also reported that the inhibition of cholesterol biosynthesis in hepatocytes suppressed HCC growth via the TAZ/TEAD2 pathway. This evidence concerns the gene TEAD2 and hepatocellular carcinoma.